Create a free account or log in.
We are a fully integrated biotechnology company focused on discovering, developing, and commercializing innovative medicines. We are committed to improving patients’ lives worldwide by targeting diseases with high unmet needs. Our R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Our portfolio comprises discovery through to Phase 4 programs in immunology, oncology, and other indications. Our first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan.
Worldwide
Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).
| Filing Information | Date & Language | Document Details | Actions |
|---|
No filings found matching your criteria
| Person (Position) | Type | Volume | Price | Date |
|---|---|---|---|---|
|
↑
Contamine Jérôme
(Board)
|
Buy | EUR 30,800.87 | EUR 26.60 | 10.01.25 |
|
↑
Guenter Peter
(Board)
|
Buy | EUR 24,603.46 | EUR 26.60 | 10.01.25 |
|
↑
Svanberg Elisabeth
(Board)
|
Buy | EUR 24,348.15 | EUR 26.61 | 10.01.25 |
|
↑
Huston Thad
(Board)
|
Buy | EUR 0.00 | EUR 0.00 | 03.07.24 |
|
↑
Stoffels IMC
(Board)
|
Buy | EUR 0.00 | EUR 0.00 | 17.05.24 |
|
◆
Stoffels IMC
(Board)
|
Other | EUR 1,428,334.05 | EUR 28.05 | 01.05.24 |
|
◆
Missotten Annelies
(Board)
|
Other | EUR 373,990.65 | EUR 28.05 | 01.05.24 |
|
◆
Cnossen Valeria
(Board)
|
Other | EUR 368,885.55 | EUR 28.05 | 01.05.24 |
|
◆
Huston Thad
(Board)
|
Other | EUR 354,439.80 | EUR 28.05 | 01.05.24 |
|
◆
GILEAD THERAPEUTICS A1 UNLIMITED COMPANY
(Close relation)
|
Other | EUR 0.00 | EUR 0.00 | 30.04.24 |
549300QKJ78IY0IOV655
IKM
Sector
Health Care
Country
Spain
ISIN
Founded
1NKEMIA specializes in biotechnology research and innovation, offering advanced solutions for the pharmaceutical, chemical, and energy sectors.
2CUREX
Sector
Health Care
Country
Sweden
ISIN
SE0010468124
Founded
2cureX AB is a Danish biotech company specializing in functional precision medicine. It develops diagnostic tools to personalize cancer treatment.
VSC
Sector
Health Care
Country
Germany
ISIN
DE000A3E5C40
Founded
1997
4SC focuses on the development of novel small molecule drugs that target key mechanisms of cancer development, such as histone …
ABERA
Sector
Health Care
Country
Sweden
ISIN
SE0015245097
Founded
Abera Bioscience is active in biotechnology. The company specializes in the development of vaccines based on its own internal developed …
ABNX
Sector
Health Care
Country
France
ISIN
FR0012616852
Founded
ABIONYX Pharma is a new-generation biotech company that aims to contribute to health through innovative therapies in indications where there …
ABLI
Sector
Health Care
Country
Sweden
ISIN
SE0002575340
Founded
2000
Abliva develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare and often very severe diseases occur when …